This announcement is a separate document:
大参林：大参林医药集团股份有限公司关于可转换公司债券2022年跟踪评级结果的公告
Dashenlin: Announcement by Dashenlin Pharmaceutical Group Co., Ltd. on the tracking rating results of convertible corporate bonds in 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.